Abstract
Correction to: npj Vaccineshttps://doi.org/10.1038/s41541-024-00911-2, published online 26 June 2024 In the original version of this Article, the vaccine concentrations used in the in vitro experiments were written mistakenly with a 10-fold error. The actual concentration used was 0.5 μg/ml resulting in a 0.5 pg/ml end-organ dose (Discussion). In Methods section Stimulation “of injected dose” was missing after “~0.1%”, and the final concentration of vaccine in blood should have been 0.006 μg/ml. A clarification is added that “This concentration also mimics ~0.8% of the IM injected dose found in the Plasma 1 h post injection.” Throughout the rest of the Methods the stock concentration should have been 500 μg/ml and the injected dose 0.5 μg/ml. The Article has now been corrected with these changes. This correction does not change the scientific conclusions of the article.
| Original language | English |
|---|---|
| Article number | 172 |
| Journal | npj Vaccines |
| Volume | 9 |
| Issue number | 1 |
| DOIs |
|
| State | Published - Dec 2024 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Immunology
- Pharmacology
- Infectious Diseases
- Pharmacology (medical)
Fingerprint
Dive into the research topics of 'Correction to: The direct effect of SARS-CoV-2 virus vaccination on human ovarian granulosa cells explains menstrual irregularities (npj Vaccines, (2024), 9, 1, (117), 10.1038/s41541-024-00911-2)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver